Epclusa tablets (sofosbuvir and velpatasvir) by Gilead

Epclusa® Tablets by Gilead are a prescription antiviral medication indicated for the treatment of chronic hepatitis C virus (HCV) infection in adults. Epclusa® combines sofosbuvir and velpatasvir, which work together to inhibit key viral enzymes, preventing HCV replication and helping to achieve a sustained virologic response. This once-daily oral therapy is effective across all major HCV genotypes and is typically used under the supervision of a qualified healthcare professional, with appropriate pre-treatment evaluation and monitoring to ensure safe and effective treatment outcomes.